title: IL-1 beta, a strong mediator for glucose uptake by rheumatoid and non-rheumatoid cultured human synoviocytes.
abstract: Higher basal 2-deoxy-D-glucose uptake in rheumatoid synovial cells than in non-rheumatoid synovial cells, was found to be associated with an increased interleukin-1 beta (IL-1 beta) secretion (respectively 850 +/- 238 vs. 8.3 +/- 2.4 pg/24 h/10(5) cells, mean +/- S.E.M.). When exogenous human recombinant IL-1 beta was added to cultures, a marked stimulation of 2-deoxy-D-glucose uptake was performed by both human synovial cultured cells, in a time-dependent and dose-dependent manner (IL-1 beta 0-100 ng/ml). In non-rheumatoid synoviocytes, stimulation occurred 1-3 h following the addition of 1 ng/ml interleukin-1 beta and increased up to 24 hours (respectively +150% and +261.4% after 6 and 24 hours association time). Rheumatoid synovial cells were less sensitive to 1 ng/ml IL-1 beta (respectively +80% and +146.4%). IL-1 beta increased significantly the Vmax for 2-deoxy-D-glucose uptake by synovial cells, with no change in the Km. This effect was protein synthesis-dependent, and not secondary to prostaglandin E2 synthesis or cell growth. IL-1 beta possesses an important effect on glucose homeostasis in synovial cells, which could be indirect and/or regulated by the presence of natural inhibitors.
authors.affiliation: Biochimie Cellulaire de l'Inflammation, Université Paris XI, Chatenay-Malabry, France.
authors.forename: A
authors.initials: A
authors.lastname: Hernvann
authors.forename: C
authors.initials: C
authors.lastname: Aussel
authors.forename: L
authors.initials: L
authors.lastname: Cynober
authors.forename: N
authors.initials: N
authors.lastname: Moatti
authors.forename: O G
authors.initials: OG
authors.lastname: Ekindjian
mesh_terms: D001172:Arthritis, Rheumatoid / Q000378:metabolism*; D002478:Cells, Cultured; D003513:Cycloheximide / Q000494:pharmacology; D003847:Deoxyglucose / Q000378:metabolism; D015232:Dinoprostone / Q000378:metabolism; D004797:Enzyme-Linked Immunosorbent Assay; D005947:Glucose / Q000378:metabolism*; D006801:Humans; D007213:Indomethacin / Q000494:pharmacology; D007375:Interleukin-1 / Q000494:pharmacology*; D008934:Mitogens; D013583:Synovial Membrane / Q000166:cytology / Q000187:drug effects / Q000378:metabolism*
chemical_list: D007375:Interleukin-1; D008934:Mitogens; D003513:Cycloheximide; D003847:Deoxyglucose; D005947:Glucose; D015232:Dinoprostone; D007213:Indomethacin